Abstract

This study aimed at investigating the regulation of the expression of myosin regulatory light chain (Mrlc) interacting protein (Mylip) gene by 17β-estradiol (E2) and the role of this sex hormone in contractile function. Eleven-month old male C57BL/6J mice were injected intraperitonealy with 10−8 M E2 (n = 6) or vehicle (Ctrl; n = 4) and female C57BL/6J mice of 13–14 months with E2 (n = 8) or vehicle (Ctrl; n = 5). Five hours after injection, cardiomyocytes (CMs) were isolated and were either frozen in TRIzol reagent for RNA isolation or used for cell shortening measurements. Quantitative real-time PCR revealed that E2-treated male CMs had higher Mylip levels than Ctrl CMs (adjusted P = 0.05), while E2 had no effect in Mylip levels of female CMs compared to Ctrl CMs. In addition, there was a decreased abundance in Mrlc in male CMs compared to Ctrl CMs (adjusted P < 0.001), while Mrlc levels did not change in the CMs of female mice. Recordings of unloaded cell shortening at 1, 2 and 4 Hz demonstrated that the treatment with E2 impaired contractile function in male CMs compared to Ctrl CMs at 1 Hz (adjusted P < 0.01) and at 2 Hz (adjusted P < 0.05), while there was an increasing trend in cell contraction of female CMs compared to Ctrl CMs, which reached statistical significance only at 1 Hz (adjusted P = 0.05). In conclusion, we have identified a CM- and sex-specific effect of E2 that regulates contractile function.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.